DOI:
10.1055/s-00000045
Der Nuklearmediziner
LinksClose Window
References
Imhof A, Brunner P, Marincek N. et al.
Response, survival, and long-term toxicity after therapy with the radiolabeled somatostatin analogue [90Y-DOTA]-TOC in metastasized neuroendocrine cancers.
J Clin Oncol 2011;
29: 2416-2423
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.